Regular Article THROMBOSIS AND HEMOSTASIS Solution structure of the major factor VIII binding region on von Willebrand factor
نویسندگان
چکیده
• The high-resolution structure of the complex disulfidebonded TIL9E9 (D9) region of VWF is presented. • The major factor VIII binding site is localized around a flexible region on the TIL9 domain. Althoughmuchof the functionof vonWillebrand factor (VWF)hasbeen revealed, detailed insight into the molecular structure that enables VWF to orchestrate hemostatic processes, in particular factor VIII (FVIII) binding and stabilization in plasma, is lacking. Here, we present the high-resolution solution structure and structural dynamics of the D9 regionof VWF,which constitutes themajor FVIII bindingsite. D9 consists of 2 domains, trypsin-inhibitor–like (TIL9) and E9, of which the TIL9 domain lacks extensive secondary structure, is strikinglydynamicandharbors a cluster of pathologicalmutations leading to decreased FVIII binding affinity (type 2N von Willebrand disease [VWD]). This indicates that the backbonemalleability of TIL9 is important for its biological activity. The principal FVIII binding site is localized to a flexible, positively charged region on TIL9, which is supported by the rigid scaffold of the TIL9 and E9 domain b sheets. Furthermore, surfacechargemappingof theTIL9E9 structure reveals apotentialmechanism for theelectrostatically guided, high-affinity VWF×FVIII interaction.Our findingsprovidenovel insights intoVWF×FVIII complex formation, leading to a greater understanding of the molecular basis of the bleeding diathesis type 2N VWD. (Blood. 2014;123(26):4143-4151)
منابع مشابه
Evaluation of Normal Range of Bleeding Scores in Healthy Iranian Adults using the International Society on Thrombosis and Hemostasis Bleeding Assessment Tool
Background: Bleeding assessment tools are key components in the evaluation of patients suspicious for bleeding disorders. The exact determination of the normal ranges of ISTH-BAT (International Society on Thrombosis and Hemostasis –Bleeding Assessment Tool) in the healthy population is a crucial step for determining who needs to be referred for further coagulation laboratory examinations. We ai...
متن کاملvon Willebrand factor: more than a regulator of hemostasis and thrombosis.
von Willebrand factor (vWF) was first identified as an adhesive glycoprotein involved in hemostasis by Zimmermann in 1971. Since then, vWF has been shown to play a vital role in platelet adhesion, platelet binding to collagen and factor VIII protection. Recent studies have implicated vWF as a regulator of angiogenesis, smooth muscle cell proliferation, tumor cell metastasis and crosstalk in the...
متن کاملLaboratory Testing for von Willebrand Disease: The Past, Present, and Future State of Play for von Willebrand Factor Assays that Measure Platelet Binding Activity, with or without Ristocetin.
von Willebrand disease (VWD) was first described nearly a century ago in 1924 by Erik Adolf von Willebrand. Diagnostic testing at the time was very limited and it was not until the mid to late 1900s that more tests became available to assist with the diagnosis and classification of VWD. Two of these tests are based on ristocetin, one being ristocetin-induced platelet aggregation (RIPA) and the ...
متن کاملWillebrand factor concentrate: a prospective, multicenter study Treatment of von Willebrand disease with a high-purity factor VIII/von
http://bloodjournal.hematologylibrary.org/cgi/content/full/99/2/450 Updated information and services can be found at: (2368 articles) Hemostasis, Thrombosis, and Vascular Biology (2342 articles) Clinical Trials and Observations collections: Blood Articles on similar topics may be found in the following http://bloodjournal.hematologylibrary.org/misc/rights.dtl#repub_requests Information ab...
متن کاملHEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF
While studying patient plasma containing an unusual pattern of von Willebrand factor (VWF) multimers, we discovered a previously unreported phenomenon: heavy predominance of dimeric VWF. Genomic analysis revealed a new congenital mutation (Tyr87Ser) that altered the final stages of VWF biosynthesis. This mutation in the propeptide (VWFpp) resulted in synthesis of dimeric VWF with an almost comp...
متن کامل